Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Centers for Disease Control and Prevention - ERA · Department of Health and Human Services · RFA-TS-27-018
In plain English
Centers for Disease Control and Prevention - ERA (Department of Health and Human Services) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet. Estimated posting date: Oct 1, 2026 (this estimate has passed and the agency has not posted it yet). Estimated application due date: Dec 1, 2026.
Awards are up to $500,000 each, the agency expects to make 3 awards and estimated total program funding is $4,500,000.
Eligibility is listed as unrestricted (open to any type of applicant), subject to any clarification in the listing.
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Forecasted: not open yet |
|---|---|
| Agency note on the deadline | Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Estimated posting date | Oct 1, 2026 (estimate has passed) |
| Estimated application due date | Dec 1, 2026 |
| Estimated award date | Aug 29, 2027 |
| Estimated project start | Sep 30, 2027 |
| Fiscal year | 2027 |
| Forecast posted | Jul 8, 2026 |
| Opportunity number | RFA-TS-27-018 |
| Agency | Centers for Disease Control and Prevention - ERA (Department of Health and Human Services) |
| Funding instrument | Cooperative agreement |
| Category | Health |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | $500,000 |
| Award floor (min per award) | Not stated |
| Estimated total program funding | $4,500,000 |
| Expected number of awards | 3 |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 93.061 – Innovations in Applied Public Health Research |
| Last updated on Grants.gov | Jul 8, 2026 |
Who can apply
Browse similar: Nonprofits · State governments · Local governments · Tribal governments & organizations · Colleges & universities · School districts · Public housing authorities
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Native American tribal governments (federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than federally recognized tribal governments)
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Private institutions of higher education
- Others (see the eligibility details in the listing)
- Unrestricted (open to any type of entity above, subject to clarification in the listing)
Additional eligibility information (excerpt from the listing):
Additional Eligibility Information to be included in the NOFO.
Description
Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):
CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological …
More Department of Health and Human Services grants closing soon
All →- 2days leftNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
More health grants closing soon
All →- 5days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 6days leftSingle Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftPrevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftFeasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth